FDA Approved: QUZYTTIR — Supplemental Application (TerSera Therapeutics LLC)

View source ↗

Summary

FDA approves a supplemental application for QUZYTTIR (cetirizine hydrochloride) filed by TerSera Therapeutics, updating the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Urticaria

Drugs mentioned

• QUZYTTIR (cetirizine hydrochloride)

Snippet

SUPPL AP for QUZYTTIR (CETIRIZINE HYDROCHLORIDE)